期刊文献+

星点设计-效应面法优化非洛地平双层渗透泵控释片 被引量:4

Optimization of push-pull osmotic pump controlled release tablets containing felodipine by central composite design-response surface methodology
原文传递
导出
摘要 目的:通过星点设计-效应面法优化非洛地平双层渗透泵控释片处方。方法:以含药层片芯中氯化钠、助推层聚氧化乙烯用量、羟丙甲基纤维素用量、包衣液中醋酸纤维素与PEG4000的比例及包衣增重为自变量,以2,8,12,16h的累积释放度为考察指标,计算总评归一值,分别进行多元线性和非线性拟合,根据模型绘制效应面和等高线图及设定的2,8,12,16h释药目标值及总评归一值,确定优化处方,最后进行验证。结果:二次多项式模型比多元线性模型置信度高;优化处方各设定指标的预测值和测定值非常接近。结论:采用星点设计-效应面法,得到了基于二次多项式模型的非洛地平双层控释片处方优化模型,实现了该控释片的处方优化。 OBJECTIVE To optimize the formulation of push pull osmotic pump controlled release tablets containing teloalpine by the central composite design-response surface methodology. METHODS In the formulation design, the effects of five independence variables,the amount of NaCl,PEO,HPMC K4M, the ratio of cellulose to PEG 4000, tablet weight gain for membrane coating, were evaluated. Response variables selected in the research were in vitro cumulative releases at 2,8,12 and 16 h. The data were transformed in desirabilities. Overall desirability was calculated from the geometric mean of the four desirabilities of each formulation. Muhilinear and quadratic models were used to estimate the relationship between the dependent and the independent variables,and to delineate RSM and contour plots in order to select the optimal formulations. RESULTS The optimized area predicted by quadratic model had better prediction capability than that by muhilinear model. In vitro release test indi- cated that there existed high approximation between the observed and estimated values. CONCLUSION The multi-objective simultaneous optimization of push pull osmotic pump controlled release tablets containing felodipine could be achieved by the central composite design and response surface methodology.
作者 何艳 辛华雯
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2010年第19期1634-1638,共5页 Chinese Journal of Hospital Pharmacy
关键词 非洛地平 渗透泵 星点设计 效应面法 felodipine osmotic pump central composite design respose surface
  • 相关文献

参考文献9

  • 1Giannakou SA, Dallas PP, Rekkas DM, et al. In vitro evaluation of nimodipine permeation through human epidermis using response surface methodology [J]. Int J Pharm, 2002,241 ( 1 ) : 27-34.
  • 2Kagkadis KA, Rekkas DM, Dallas PP, et al. A freeze-dried injection form of flurbiprofen: development and optimization using response surface methodology[J]. Int J Pharm, 1998, 161 (1) : 87-94.
  • 3陆彬,吴伟.中心多点等距设计法优化醋酸地塞米松聚丙交酯微球的制备工艺[J].药学学报,1999,34(5):387-391. 被引量:44
  • 4Mclay JS, MacDonald TM, Hosie J, et al. The pharmacodynamic and pharmacokinetie profiles of controlled-release formulations of felodipine and metoprolol in free and fixed combinations in elderly hypertensive patients[J]. Eur J Clin Pharmacol,2000,56: 529-535.
  • 5Verrna RK, Mishra B, Garg S. Osmotically controlled oral drug delivery[J]. Drug Dev Ind Pharm,2000,26(7) : 695-708.
  • 6Hassan EE, Parish RC, Gallo JM, et al. Optimized formulation of magnetic chitosan microspheres containing the anticancer agent,oxantrazole[J]. Pharm Res, 1992,9(3) : 390-397.
  • 7甘勇,周新腾,胡建平,潘卫三,张汝华.格列吡嗪双层渗透泵控释片的制备及体外释放度考察[J].沈阳药科大学学报,2002,19(3):157-160. 被引量:16
  • 8李伟,张志宏,杜玍妮,聂淑芳,杨星钢,潘卫三.格列齐特推拉式渗透泵的制备[J].中国新药杂志,2008,17(3):233-236. 被引量:7
  • 9美国药典.USP30-NF25ES3.2007:2114.

二级参考文献17

  • 1王鹏,王玉珠,沈建民.均匀设计及其在药学中的应用[J].沈阳药学院学报,1989,6(4):297-305. 被引量:74
  • 2王剑红,陆彬,胥佩菱,包定元,张自然.肺靶向米托蒽醌明胶微球的研究[J].药学学报,1995,30(7):549-555. 被引量:25
  • 3邱相君,黄成坷,钱昕,胡国新,代宗顺.格列齐特的人体生物等效性研究[J].医药导报,2006,25(9):874-876. 被引量:5
  • 4[1]Kuczynski AL, Ayer AD, Wong PSL, et al. Oral hypoglycemic glipizide granulation [P]. US: 5024843,1991-06-18.
  • 5[2]Kuczynski AL, Ayer AD, Wong PSL, et al. Dosage form for administering oral hypoglycemic glipizide [P].US: 5545413, 1996-08-13.
  • 6[3]Swanson DR, Barclay BL, Wong PSL, et al. Nifedipine gastrointestinal therapeutic system [J]. Am J Med, 1987,83(suppl 6B):3-10.
  • 7[4]Vinod PS, Yi TS, Pradeep S, et al. In vitro Dissolution profile comparison-statistics and analysis of the similarity factor, f2 [J]. Pharm Res, 1998,15(6):889-896.
  • 8吴伟,中国药师,1999年,2卷
  • 9陆彬,药物研究,1998年,229页
  • 10Berger A S,Invest Ophthalmol Vis Sci,1996年,37卷,2318页

共引文献62

同被引文献43

  • 1颜廷旭,杨星钢,程洁,王启明,潘卫三.四逆散双层渗透泵控释片片芯单因素考察[J].中国药剂学杂志(网络版),2010(2):64-73. 被引量:6
  • 2吴水金,马欣莹,张美薇,杨徐洋,傅彦妍,王中彦.星点设计-效应面法优化黄藤素胃漂浮片处方[J].中国药剂学杂志(网络版),2014,12(3):97-102. 被引量:1
  • 3王锐利,张淑秋.胃漂浮片的研究进展[J].山西医科大学学报,2005,36(2):260-262. 被引量:23
  • 4杨星钢,张国华,李伟,潘卫三.阿昔莫司缓释片的体外释放度与犬体内吸收相关性[J].中国新药与临床杂志,2005,24(7):508-511. 被引量:8
  • 5中国药典一部[S].2010年:32.
  • 6Liu L,Chen B.Preparation of monolithic osmotic pump system by coating the indented core tablet[J].Eur J Pharm Biopharm,2006,64(2):180-184.
  • 7Iskandaram B,Clair JH,Patel P,et al.Simultaneous optimization of capsule and tablet formulation using response surface methodology[J].J Drug Dev Ind Pharm,1993,19(16):2089-2101.
  • 8Abu-Izza KA,Garcia-Contreras L,Lu DR.Preparation and evaluation of sustained release AZT-1oaded microspheres:optimization of the release characteristics using response surface methodology[J].J Pharm Sci,1996,85(2):144-149.
  • 9Abu-Izza KA,Garcia-Contreras L,Lu DR.Preparation and evaluation of zidovudine-loaded sustained-release microspheres.2.Optimization of multiple response variable[J].J Pharm Sci,1996,85(6):572-576.
  • 10Branchu S,Forbes RT,York P,et a1.A central composite design to investigate the thermal stabilization of lysozyme[J].Pharm Res,1999,16(5):702-708.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部